Update
Exin Therapeutics Uses AI for Mouse Brain Injection
Exin Therapeutics, a San Francisco biotech startup, has used an AI agent to run a mouse brain injection experiment. The AI agent reviewed 19 candidate gene therapies and selected one to boost GABA, the brain's main chemical brake. The agent calculated precise injection coordinates and executed the delivery using a motorized stereotaxic rig, with human supervision. The experiment took place on or around October 27-28, 2026.